This year, 36 percent of Google Ventures’ invested capital went toward healthcare and life sciences, up from 9 percent in both 2013 and 2012, according to the report.
And, Google has no plans to stop. “Barring some huge calamity, we’ll see more interesting things in life sciences in 2015, said Bill Maris, head of Google Ventures, in the report.
Hints toward what could be coming include hiring at the Life Sciences team at Google X, the company’s research lab. In 2013, Andrew Conrad, a genetics expert, joined Google X and is analyzing the genetic and molecular information of thousands of people with the hopes of creating a “more-complete picture of a healthy human being,” according to the report. Additionally, Google Ventures invested $130 million in Flatiron Health — an aggregator of patient cancer data — in 2014 at the suggestion of Mr. Conrad, making it the largest healthcare software investment Google Ventures has funded to date, according to the report.
More articles on IT investments:
Mayo Clinic partners with startup accelerator Techstars
Why are so many tech companies entering healthcare? 5 key factors
MATTER launches in-residence program of health tech startups
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.